These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39083921)

  • 21. Characterization and exploration of an artifact in the reducing capillary electrophoresis-sodium dodecyl sulfate analysis of the 'me-too' drug zuberitamab related to rituximab.
    Gao H; Wang ST; Wang H; Fang WJ
    J Pharm Biomed Anal; 2023 May; 228():115347. PubMed ID: 36934619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Trends in the Quality Control of Enantiomeric Drugs: Quality by Design-Compliant Development of Chiral Capillary Electrophoresis Methods.
    Orlandini S; Hancu G; Szabó ZI; Modroiu A; Papp LA; Gotti R; Furlanetto S
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intact mass analysis of monoclonal antibodies by capillary electrophoresis-Mass spectrometry.
    Han M; Rock BM; Pearson JT; Rock DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():24-32. PubMed ID: 26751590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of ADCs by Capillary Electrophoresis.
    Ning W; Zhao Y
    Methods Mol Biol; 2020; 2078():251-262. PubMed ID: 31643062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-capillary approach to eliminate SDS interferences in antibody analysis by capillary electrophoresis coupled to mass spectrometry.
    Sánchez-Hernández L; Montealegre C; Kiessig S; Moritz B; Neusüß C
    Electrophoresis; 2017 Apr; 38(7):1044-1052. PubMed ID: 28008632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of CE-based baseline disturbances using simulation and targeted experimental evaluation-impact on the purity determination of therapeutic proteins.
    Gu Y; Voronov S; Ding J; Mussa N; Li ZJ
    Anal Bioanal Chem; 2019 Apr; 411(11):2425-2437. PubMed ID: 30880351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CE-SDS method development, validation, and best practice-An overview.
    Sänger-van de Griend CE
    Electrophoresis; 2019 Sep; 40(18-19):2361-2374. PubMed ID: 31141192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method development and validation of capillary sodium dodecyl sulfate gel electrophoresis for the characterization of a monoclonal antibody.
    Zhang J; Burman S; Gunturi S; Foley JP
    J Pharm Biomed Anal; 2010 Dec; 53(5):1236-43. PubMed ID: 20719453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four-step approach to efficiently develop capillary gel electrophoresis methods for viral vaccine protein analysis.
    Geurink L; van Tricht E; Dudink J; Pajic B; Sänger-van de Griend CE
    Electrophoresis; 2021 Jan; 42(1-2):10-18. PubMed ID: 32640046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of an Uncommon Artifact during Reducing Capillary Electrophoresis-Sodium Dodecyl Sulfate Analysis of a Monoclonal Antibody with Dynamic Light Scattering and Reversed Phase High-Performance Liquid Chromatography.
    Gao H; Wang ST; Hu F; Shen BB; Sun MF; Wang H; Li L; Fang WJ
    Pharm Res; 2022 Aug; 39(8):1959-1968. PubMed ID: 35701679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of capillary electrophoresis sodium dodecyl sulfate (CE-SDS) method for purity analysis of pertussis toxin, filamentous haemagglutinin and pertactin antigens.
    Thorat S; Ogale P; Gautam M; Shaligram U; Gairola S
    Vaccine; 2023 Sep; 41(40):5854-5862. PubMed ID: 37591705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using capillary electrophoresis sodium dodecyl sulfate (CE-SDS) and liquid chromatograph mass spectrometry (LC-MS) to identify glycosylated heavy chain heterogeneity in the anti-VEGFR-2 monoclonal antibody.
    Li M; Zhao X; Wu G; Wang W; Du J; Xu G; Duan M; Fu Z; Yu C; Wang L
    Electrophoresis; 2024 Aug; 45(15-16):1281-1294. PubMed ID: 38361212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of CE-SDS gel for characterization of monoclonal antibody hinge region clipping due to copper and high pH stress.
    Rustandi RR; Wang Y
    Electrophoresis; 2011 Nov; 32(21):3078-84. PubMed ID: 22145164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using enhanced development tools offered by analytical Quality by Design to support switching of a quality control method.
    Simeoni P; Deissler M; Bienert R; Gritsch M; Nerkamp J; Kirsch S; Roesli C; Pohl T; Anderka O; Gellermann G
    Biotechnol Bioeng; 2023 Nov; 120(11):3299-3310. PubMed ID: 37526307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Multi-Attribute Characterization of Enveloped and Non-Enveloped Viral Particles by Capillary Electrophoresis.
    Fernandes RP; Escandell JM; Guerreiro ACL; Moura F; Faria TQ; Carvalho SB; Silva RJS; Gomes-Alves P; Peixoto C
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of capillary electrophoresis in glycoprotein analysis.
    Rustandi RR; Anderson C; Hamm M
    Methods Mol Biol; 2013; 988():181-97. PubMed ID: 23475720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Experimental Design Methodologies in the Enantioseparation of Pharmaceuticals by Capillary Electrophoresis: A Review.
    Hancu G; Orlandini S; Papp LA; Modroiu A; Gotti R; Furlanetto S
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of glycosylation for quality assurance of antibody pharmaceuticals by capillary electrophoresis.
    Kamoda S; Kakehi K
    Electrophoresis; 2008 Sep; 29(17):3595-604. PubMed ID: 18803221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and elimination of artificial non-covalent light Chain dimers in reduced CE-SDS analysis of pertuzumab.
    Zhang L; Fei M; Tian Y; Li S; Zhu X; Wang L; Xu Y; Xie MH
    J Pharm Biomed Anal; 2020 Oct; 190():113527. PubMed ID: 32911382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of orthogonal NISTmAb size heterogeneity control methods.
    Turner A; Yandrofski K; Telikepalli S; King J; Heckert A; Filliben J; Ripple D; Schiel JE
    Anal Bioanal Chem; 2018 Mar; 410(8):2095-2110. PubMed ID: 29428991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.